VisuVivo – A proliferation marker to visualise cell cycle progression in vitro and in vivo with high spatial resolution
The invention provides a nucleic acid expression construct
encoding a fusion protein comprising a fluorescence reporter protein (like EGFP) and a protein with a wild-type destruction signal (like Anillin). Localised to subcellular structures during cell cycle progression, it presents a fluorescence marker for imaging cell cycle progression in vitro and in vivo. Challenge The cell cycle comprises consecutive phases termed G1, S (synthesis), G2 (interphase) and M (mitosis). Cells that temporarily or reversibly stop dividing enter quiescence, named the G0-phase. To differentiate between cells that start to divide again and resting cells is still an unreached goal. In addition, available cell cycle indicators are unable to distinguish between cell division and acytokinetic mitosis which is karyokinesis without cyotkinesis or endoreplication which is continuing rounds of DNA replication without karyokinesis.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Sensitive ceramics for soft robotics
Most people think of coffee cups, bathroom tiles or flower pots when they hear the word “ceramic”. Not so Frank Clemens. For the research group leader in Empa’s Laboratory for…
‘Entirely unanticipated’ role of protein netrin1 in spinal cord development
Known for its axon guidance properties, new research suggests protein is critical in guiding neural development. Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research…
AI to improve brain cancer diagnosis, monitoring, treatment
Recommendations published in The Lancet Oncology call for good clinical practice of new technologies to modernize decades-old standard of care for brain cancer patients. An international, multidisciplinary team of leading…